To the full analysis
Medtronic Plc stock: valuation and P/E
MDTMedtronic Plc trades at a P/E of 24.8 (Medical (Devices) median 29.1, own median of recent years 28.1).
Daily figure as of 13 Nov 2026
P/E
24.8
on reported earnings of the last twelve months
P/S
3.4
P/B
2.58
PEG
3.33
P/E on expected earnings
The forward P/E of 16.3 divides the price by the earnings per share that 17 analysts expect on average for the next twelve months: $6.21. The twelve months are made up pro rata of the estimates for fiscal 2027 and 2028. The P/E of 24.8, by contrast, uses reported earnings for the last twelve months.
16.3
P/E on fiscal 2027
16.9
on estimated fiscal 2027 earnings ($5.98 per share)
P/E on fiscal 2028
15.8
on estimated fiscal 2028 earnings ($6.39 per share)
Analysts mostly estimate adjusted earnings, excluding amortization of acquisitions and other one-off items. The estimates change all the time; they are no promise and no price target.
Against its own valuation history
Each fiscal year is shown with its P/E on the year-end date, using the price at the time.
P/E
24.8
Median of prior years
28.1
Reading
cheaper than usual
P/E at each fiscal year end
Figures as a table
| Year | P/E |
|---|---|
| 2017 | 28.5 |
| 2018 | 35.5 |
| 2019 | 25.4 |
| 2020 | 27.3 |
| 2021 | 48.9 |
| 2022 | 27.8 |
| 2023 | 32.1 |
| 2024 | 28.8 |
| 2025 | 23.2 |
| 2026 | 22.2 |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 24 Apr 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.